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Abstract
Background: Prison populations are known to be at high risk of sexually transmitted infections
(STIs) and blood borne viruses (BBVs). In accordance with State health guidelines, the Western
Australian Department of Correctional Services' policy is to offer testing for STIs and BBVs to all
new prison entrants. This audit was undertaken to assess the completeness and timeliness of STI
and BBV testing among recent prison entrants in Western Australia, and estimate the prevalence
of STIs and BBVs on admission to prison.
Methods: A retrospective audit of prison medical records was conducted among 946 individuals
admitted to prison in Western Australia after the 1st January 2005, and discharged between the 1st
January and 31st December 2007 inclusive. Quota sampling was used to ensure adequate sampling
of females, juveniles, and individuals from regional prisons. Main outcomes of interest were the
proportion of prisoners undergoing STI and BBV testing, and the prevalence of STIs and BBVs.
Results: Approximately half the sample underwent testing for the STIs chlamydia and gonorrhoea,
and almost 40% underwent testing for at least one BBV. Completeness of chlamydia and
gonorrhoea testing was significantly higher among juveniles (84.1%) compared with adults (39.8%;
p < 0.001), and Aboriginal prisoners (58.3%) compared with non-Aboriginal prisoners (40.4%; p <
0.001). Completeness of BBV testing was significantly higher among adults (46.5%) compared with
juveniles (15.8%; p < 0.001) and males (43.3%) compared with females (33.1%; p = 0.001). Among
prisoners who underwent testing, 7.3% had a positive chlamydia test result and 24.8% had a positive
hepatitis C test result.
Conclusion: The documented coverage of STI and BBV testing among prisoners in Western
Australia is not comprehensive, and varies significantly by age, gender and Aboriginality. Given the
high prevalence of STIs and BBVs among prisoners, increased test coverage is required to ensure
optimal use of the opportunity that prison admission presents for the treatment and control of STIs
and BBVs among this high risk group.
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Background
Prison populations frequently engage in behaviours
which put them at high risk for the transmission of sexu-
ally transmitted infections (STIs) and blood borne viruses
(BBVs) [1,2]. The prevalence of STIs and BBVs is higher
among prisoners than the general population, both in
Australia [1,3] and elsewhere [4]. Control of STI and BBV
transmission among high risk populations can contribute
significantly to disease control in the wider population
[5], particularly when disease transmission generally
occurs in densely connected social networks [6].
Development of appropriate policy to address the public
health needs of prisoners continues to present challenges
in many countries [7-11]. Effective implementation of
policies designed to improve prisoner health is also criti-
cal to the achievement of improved health outcomes
among prisoners, and it is important that these policies
and programs are adequately evaluated.
Department of Health guidelines in Western Australia
[12] recommend opportunistic testing for STIs and BBVs
among individuals who have a history of behavioural risk
factors. In accordance with these guidelines, the Western
Australian Department of Corrective Services' policy is to
offer STI and BBV testing to all new prison entrants. To
determine whether documented prisoner health assess-
ment practices are consistent with STI and BBV testing
policy, an audit was conducted to assess the completeness
and timeliness of STI and BBV testing among prisoners in
Western Australia, and estimate the prevalence of STIs and
BBVs on admission to prison.
Methods
Setting
Western Australia has a total of 13 correctional facilities
for adults, seven of which are within the greater metropol-
itan area of Perth. In the metropolitan area, prisoners on
remand are managed at one of three prisons which pro-
vide separate services for adult males, adult females, and
juveniles [13].
During the 2006-07 financial year, the daily average adult
prisoner population in Western Australia was 3623 per-
sons, with over 8180 adult prisoner admissions during
this period. The daily average juvenile prisoner popula-
tion in Western Australia was 139 persons, with a total of
1688 juvenile prisoner admissions during this period
[14]. In 2007 approximately 8.5% of adult prisoners in
Western Australia were female, and 42.9% were Aborigi-
nal, which is defined here as inclusive of people of Abo-
riginal or Torres Strait Islander origin, who account for
approximately 3.5% of the total Western Australian pop-
ulation [15].
Sample
Adherence to STI and BBV testing policy was evaluated
among a sample of prisoners admitted after 1st January
2005, and discharged between 1st January 2007 and 31st
December 2007 inclusive. As all prison entrants are
required to undergo an initial health assessment, no min-
imum duration of imprisonment was specified for inclu-
sion in this audit. Prisoner records were sampled using
data from the Department of Corrective Services' Total
Offender Management System (TOMS) database, which
maintains the records of all criminal offenders in Western
Australia, and the Total Records and Information Manage-
ment (TRIM) database, which contains scanned copies of
discharged prisoners' paper medical records. Discharged
prisoners were selected for inclusion in this audit because
medical records are scanned into TRIM within four
months of discharge, and therefore were available for
examination at a central location.
Quota sampling was used to ensure that sufficient num-
bers of females, juveniles and prisoners from regional
prisons were obtained to allow meaningful subgroup
analysis by gender, age and Aboriginality. Among adult
prisoners discharged from metropolitan correctional facil-
ities, a target sample size of 200 male and 200 female pris-
oners was specified. Among juvenile prisoners discharged
from metropolitan correctional facilities, a target sample
size of 100 male and 100 female prisoners was specified.
To ensure adequate representation of prisoners from
regional prisons, a target sample size of 200 adult male
prisoners discharged from the 6 regional correctional
facilities for males was specified, and a target sample size
of 100 adult female prisoners discharged from the 4
regional correctional facilities that accommodate female
prisoners was specified. No regional correctional facilities
exist for juvenile prisoners in Western Australia, and all
juveniles audited were admitted to a single facility.
The study target sample size represents over 8% of adult
prisoner admissions and over 11% of juvenile prisoner
admissions in Western Australia per year. Eligible prison-
ers were sampled consecutively in reverse chronological
order based on the date of discharge, commencing from
the 31st December 2007. The median sentence length
among prisoners in Western Australia in 2007 was 2.7
years [15]. As such, sampling was performed in reverse
chronological order from the last possible date of dis-
charge to maximise the time between the eligible admis-
sion and discharge dates and decrease selection bias
associated with the duration of imprisonment.
Juvenile females were the least commonly discharged
sampling category, and due to the small available sample
size, the sample of juvenile females was supplemented
with eligible individuals whose records were not availableBMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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on the TRIM database but were accessible for review at the
juvenile remand centre on 9th June 2008.
Data collection
Data were collected between the 28th April and the 9th
June 2008. Examination of electronic medical records was
restricted to documents relating to the initial health
assessment and STI/BBV testing for the relevant prison
admission. The TOMS database was used to retrieve eligi-
ble prisoners' identifiers (first and last initials and identi-
fication number) and demographic data (date of birth,
sex, Aboriginality, date and location of admission and dis-
charge). The TRIM database was used to identify the
prison location where the health assessment was com-
pleted, documentation related to the uptake of STI and
BBV testing, and results of testing based on the presence of
an appropriate pathology report.
Medical and nursing staff employed by the Department of
Corrective Services conducted the audit with the approval
of the Department of Corrective Services' Director of
Health Services. Data obtained were recorded on stand-
ardised data collection forms, and entered into a pass-
word protected Microsoft Access 2002 database. Processes
used to ensure data quality during the audit process
included the use of standardised forms for data extraction
and entry, and verification of the accuracy of data entry
prior to data analysis based on the comparison of original
and extracted data, which was performed for over 10% of
the audit sample.
As the audit's primary purpose was to evaluate and
improve the quality of health care delivered to prisoners,
it complied with requirements for a quality assurance
study as defined by the National Health and Medical
Research Council, and ethics approval was not required
[16].
Admission health assessment
Prison health assessment policies [17,18] require the
assessment of a prisoner's health and wellbeing as soon as
practicable following admission. All prisoners are
required to be offered STI and BBV testing following
admission to prison, and testing is to be completed within
28 days of admission. STI and BBV testing in Western Aus-
tralian prisons is voluntary. Testing reviewed for this audit
included nucleic acid tests for chlamydia and gonorrhoea,
and serological tests for syphilis (i.e. STI tests), and sero-
logical tests for hepatitis B, C and HIV (i.e. BBV tests). A
positive chlamydia or gonorrhoea test was one in which
chlamydia or gonorrhoea nucleic acid was reported as
having been detected. A positive syphilis, hepatitis C or
HIV test was one in which antibodies to Treponema palli-
dum, hepatitis C or HIV were reported as having been
detected. A positive hepatitis B test was one in which hep-
atitis B surface antigen was reported as having been
detected.
Data analysis
Data were analysed using SPSS (version 17.0, SPSS Inc.).
Test coverage and disease prevalence results are reported
by age group, sex and aboriginality due to the significant
differences found between these subgroups. The Chi-
square test of independence was used to test for associa-
tions between demographic characteristics and the com-
pleteness and results of STI and BBV testing. Pearson Chi-
square statistics are reported using a two-sided signifi-
cance level of 0.05. Odds ratios and their 95% confidence
intervals (95%CI) are reported for significant associa-
tions.
Results
Sample
A total of 946 prisoners' records were audited (Table 1).
Overall 57.5% of the sample (n = 544) were Aboriginal.
Among adult prisoners, those sampled from regional pris-
ons were more likely to be Aboriginal (76.8%) than those
sampled from non-regional prisons (36.9%). Most
(85.9%) prisoners audited were admitted to prison in
2007, with 11.2% admitted in 2006 and 2.9% admitted in
2005. Six adults and 31 juveniles were imprisoned for less
than 24 hours, and 35 adults and 88 juveniles were
imprisoned for less than 48 hours. Among adult prisoners
who had a documented initial health assessment form on
their electronic medical record (97.1%, 919/946), the
health assessment was performed at the prison of admis-
sion for all prisoners apart from 3 prisoners, 2 of whom
were admitted to regional prisons.
Completeness of STI and BBV testing
STI testing for chlamydia and or gonorrhoea was docu-
mented for 50.5% of prisoners, and almost all of these
Table 1: Audit sample descriptive statistics by sex and age group.
Subgroup n Mean age in years (range) Mean number of days of imprisonment (range) % Aboriginal
Adult male 410 32.3 (18-66) 222.4 (0†-1019) 48.0
Adult female 302 32.7 (18-57) 107.1 (0†-912) 60.9
Juvenile male 122 15.6 (12-18) 7.8 (0†-176) 68.9
Juvenile female 112 15.7 (13-18) 22.1 (0†-334) 70.5
†duration of imprisonment of less than 24 hoursBMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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(465/478, 97.3%) had undergone testing for both
chlamydia and gonorrhoea. An additional 0.3% of pris-
oners refused testing, and 1.0% had STI tests ordered but
no results were located. The completeness of STI testing
for chlamydia and or gonorrhoea was significantly associ-
ated with age (p < 0.001, OR = 8.0 95%CI = 5.4-11.7) and
Aboriginality (p < 0.001, OR = 2.1 95%CI = 1.6-2.7), with
testing higher among juveniles (84.1%) compared with
adults (39.8%), and Aboriginal (58.3%) compared with
non-Aboriginal prisoners (40.4%). The completeness of
STI and hepatitis B and C testing by sex and Aboriginality
is summarised in Figures 1 and 2.
Syphilis test results were recorded for 24.2% of (229) pris-
oners audited. An additional 0.4% of prisoners refused
testing, and 0.8% of prisoners had a syphilis test ordered
but no results were located. Test coverage was significantly
higher among Aboriginal (28.3%) compared with non-
Aboriginal prisoners (18.7%) (p = 0.01, OR = 4.2 95%CI
= 1.3-15.2). There was no significant association between
syphilis test coverage and age (adults 27.4%, juveniles
14.5%; p = 0.08).
BBV testing was ordered or performed for either hepatitis
B, hepatitis C, or HIV for 38.3% of (362) prisoners, and an
additional 1.4% refused BBV testing. Among the prisoners
who had BBV testing ordered or performed 79.0% had
undergone testing for hepatitis B and 7.7% had a hepatitis
B test ordered but no results were available; 91.2% had
undergone testing for hepatitis C and 3.3% had a hepatitis
C test ordered but no results were available; and 86.7%
had undergone testing for HIV and 3.9% had a HIV test
ordered but no results were available. Completeness of
testing for BBVs was significantly associated with age (p <
0.001, OR = 4.6 95%CI = 3.2-6.8), and sex (p = 0.001, OR
= 1.5 95%CI = 1.2-2.0), with testing higher among adults
(46.5%) compared with juveniles (15.8%), and males
(43.3%) compared with females (33.1%).
Test coverage and timeliness by age group and prison
location is summarised in Table 2. Test coverage in the
individual adult prisons studied ranged between 12.5%
and 61.5% for STI testing, and 25.0% and 63.6% for BBV
testing. Of the testing performed, the percentage of tests
completed within 28 days of admission in the individual
adult prisons studied ranged between 16.7% and 98.4%
for STI tests and 29.0% and 85.7% for BBV tests.
STI and BBV prevalence
Positive chlamydia test results were recorded for 7.3%
(95%CI 4.9-9.7%) of the 466 prisoners tested. Among
juveniles, females were significantly more likely to have
Proportion of adults tested for STIs and BBVs (upper bar), and the proportion of the adults testing positive for STIs and BBVs  (lower bar) by sex and Aboriginality Figure 1
Proportion of adults tested for STIs and BBVs (upper bar), and the proportion of the adults testing positive for 
STIs and BBVs (lower bar) by sex and Aboriginality.BMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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positive chlamydia test results (18/89, 20.2%) than males
(2/102, 2.0%; p < 0.001, OR = 12.7 95%CI = 2.8-55.6).
Although positive chlamydia test results among Aborigi-
nal females were approximately twice the rate of positive
test results among non-Aboriginal females (Figures 1 and
2), there was no significant association between chlamy-
dia test results and Aboriginality (p = 0.08) among
females. Among males the trend was reversed, with non-
Aboriginal males more likely to have positive chlamydia
test results than Aboriginal males (p = 0.05).
Positive gonorrhoea test results were recorded for 3.4%
(95%CI 1.8-5.0%) of the 470 prisoners tested. Although
females had over twice the positivity rate of males (4.8%
versus 1.8%), and Aboriginal prisoners had over twice the
positivity rate of non-Aboriginal prisoners (4.1% versus
1.9%), gonorrhoea test results were not significantly asso-
ciated with sex or Aboriginality (p = 0.07 and p = 0.2
respectively).
Positive treponemal test results indicating present or past
syphilis infection were recorded for 11.8% (95%CI 7.6-
Proportion of juveniles tested for STIs and BBVs (upper bar), and the proportion of juveniles testing positive for STIs and BBVs  (lower bar) by sex and Aboriginality Figure 2
Proportion of juveniles tested for STIs and BBVs (upper bar), and the proportion of juveniles testing positive 
for STIs and BBVs (lower bar) by sex and Aboriginality.
Table 2: Test coverage and timeliness for sexually transmitted infections (STIs) and blood borne viruses (BBVs) by age group and 
location of prison of admission.
Test Metropolitan adults
% (n)
Regional adults
% (n)
Juveniles*
% (n)
STI coverage† 39.2 (163/416) 40.7 (120/295) 84.1 (195/232)
STI ≤ 7 days†† 71.0 (110/155) 25.6 (30/117) 97.4 (185/190)
STI ≤ 28 days†† 80.6 (125/155) 70.9 (83/117) 98.4 (187/190)
BBV coverage‡ 47.2 (193/409) 45.5 (132/290) 15.8 (37/234)
BBV ≤ 7 days‡‡ 9.1 (16/175) 15.6 (19/122) 69.7 (23/33)
BBV ≤ 28 days‡‡ 43.4 (76/175) 63.9 (78/122) 97.0 (32/33)
*There are no juvenile correctional facilities in regional Western Australia
†excludes 3 refusals (1 metropolitan adult, 2 juveniles)
††proportion of those who had STI testing and information available on the time of testing
‡excludes 13 refusals (8 metropolitan adults, 5 regional adults)
‡‡proportion of those who had BBV testing and information available on the time of testingBMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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16.0%) of the 229 prisoners tested. A non-Aboriginal
female recorded the only positive syphilis result among
the 33 juveniles tested. Among adults, Aboriginal prison-
ers were significantly more likely to have a positive syphi-
lis test result than non-Aboriginal prisoners (18.5% versus
3.1%; p = 0.003, OR = 7.1 95%CI = 1.6-31.3).
Positive hepatitis B serology results were recorded for
4.5% (95%CI 1.2-2.1%) of the 286 prisoners tested. No
positive findings occurred among juveniles. There was a
significant association between sex and hepatitis B posi-
tivity among the 253 adults tested (p = 0.02, OR = 8.5
95%CI = 1.1-66.1), with 92.3% of the positive results
occurring among males (Figure 1).
Positive hepatitis C serology or RNA test results were
recorded for 24.8% (95%CI 20.2-29.5%) of the 330 pris-
oners tested. Among the 82 individuals with positive hep-
atitis C results, 53.7% had positive RNA test results,
indicating active hepatitis C infection. Hepatitis C positiv-
ity was significantly associated with Aboriginality (p <
0.001, OR = 3.6 95%CI = 2.1-6.0), and age group (p =
0.04, OR = 3.0 95%CI = 1.0-8.7), with non-Aboriginal
prisoners more likely to have positive hepatitis C test
results (38.3%) than Aboriginal prisoners (14.8%), and
adults more likely to have positive test results (26.6%)
than juveniles (10.8%).
Among adults tested for hepatitis C, a positive test result
was significantly associated with prison location among
Aboriginal (p < 0.001, OR = 0.08 95%CI = 0.03-0.25), but
not non-Aboriginal (p = 0.7) prisoners. Aboriginal prison-
ers discharged from regional prisons were less likely to be
hepatitis C positive (4/100, 4.0%) than Aboriginal prison-
ers discharged from metropolitan prisons (21/62,
33.9%). Of the 314 prisoners tested for HIV infection,
only 2 (0.6%, 95%CI 0.2-1.5%) had positive test results,
and both were adults.
The joint evaluation of test coverage and the prevalence of
STIs and BBVs is important for the estimation of the likely
proportion of cases undetected, accounting for any target-
ing of testing, particularly if test coverage is not high. Fig-
ure 1 reveals comparatively lower rates of testing relative
to apparent disease risk for hepatitis C among females and
non-Aboriginal males, and syphilis among Aboriginal
females. Comparatively lower coverage of chlamydia test-
ing among non-Aboriginal males and juvenile non-Abo-
riginal females is also highlighted. Test refusal rates are
not displayed in Figures 1 and 2 as they were low.
Recorded rates of test refusal among the total sample were
less than 0.5% for STI testing and less than 1.4% for BBV
testing, with the greatest refusal rates on subgroup analy-
sis among adult non-Aboriginal females for BBV testing
(all ≤ 2.5%).
Discussion
Prison health assessment processes provide an important
opportunity to identify and treat STIs and BBVs among a
high risk population. Our audit found that most tests for
STIs and BBVs were performed for fewer than half of adult
prisoners, and only a small proportion of prisoners who
did not undergo testing had the refusal of testing docu-
mented on their electronic medical record. Few adult pris-
oners had very short durations of imprisonment that may
have hindered the completion of STI and BBV testing, and
compared with adults, STI test coverage was significantly
higher among juvenile prisoners who often had a very
short duration of imprisonment.
STI and BBV test coverage among adults audited was gen-
erally lower than that reported in a recent audit at a
regional prison in Western Australia, where fewer than
45% of prisoners completed STI and BBV testing within
28 days of admission [3]. Differences in audit methods,
including the audit of current practice, and the use of hard
copy medical records which are not subject to a potential
loss of information associated with the conversion to elec-
tronic format could in part explain the differences found
in test coverage. However, together these studies indicate
the need to improve the delivery of health services to pris-
oners on admission to prison.
Standardised assessment of prisoner health on admission
is a widely endorsed strategy to support improved health
care provision for prisoners [3,11,19,20]. Although docu-
mented rates of STI and BBV test refusal in our audit were
low, the impact of undocumented refusals on test cover-
age was not able to be systematically assessed. Given that
55% of prisoners in Western Australia have had a prior
adult imprisonment [15], undocumented test refusals
associated with previous testing [21] may be an important
unobserved influence on test coverage and disease preva-
lence estimates for chronic infections such as hepatitis B
and C and HIV.
Additional guidelines may be needed to ensure that STI
and BBV testing is offered to all prison entrants within 28
days of admission, that the requirements for the fre-
quency of re-testing of prisoners on readmission are
standardised, and that health assessment outcomes,
including test refusal, are fully documented. Complete
documentation of health assessment outcomes will ena-
ble more accurate monitoring of program effectiveness
and the health needs of prisoners.
Our findings are consistent with international research
which suggests that despite substantial evidence to sup-
port the effectiveness of prison health programs, consider-
able challenges confront the practical implementation of
policies to improve prisoner health [22,23]. SuccessfulBMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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implementation of recommended guidelines for improv-
ing prisoner health is critical to improved public health
[7,23]. Further research is required to identify and address
the barriers to more comprehensive health service delivery
among prisoners, and enable the development of pro-
grams that promote the acceptance of testing, treatment,
disease prevention and harm reduction strategies among
prisoners and prison staff.
This study is unique compared with previous studies of
prisoner health in Western Australia [1,3] in that we stud-
ied prisoners from both metropolitan and regional pris-
ons, and sampled a large number of females, allowing
comparisons of test coverage and disease prevalence by
sex and Aboriginality. However, as sampling was stratified
by age, sex and prison location to allow for meaningful
subgroup analysis, comparisons of overall estimates of
disease prevalence with the Western Australian prison
population which is 91.5% male and 42.9% Aboriginal
[15] may be misleading. The mean age of adult prisoners
in this study was similar to the national prison population
estimate of 35 years among males and 34 years among
females [15], and 31 years among Western Australian
prison entrants [1].
Our analysis found that prisoner sociodemographic sub-
groups with comparatively higher disease prevalence
often had higher STI and BBV test coverage, although sev-
eral areas of lower coverage relative to disease risk were
highlighted; including hepatitis C among non-Aboriginal
adult males and adult females, syphilis among Aboriginal
adult females, and chlamydia among non-Aboriginal
adult males and non-Aboriginal juvenile females. Lack of
acknowledgement of the diversity among prisoner popu-
lations and their health needs has been reported else-
where [7,24]. Our findings confirm differences in health
needs by gender, ethnicity and age, and indicate a need for
gender and culturally sensitive health services.
Disease prevalence estimates among prisoners in many
cases reflect trends in disease notification rates among the
general population, such as the high rates of chlamydia
among juvenile females and female Aboriginal prisoners.
However, the lower chlamydia testing rate among adult
male prisoners is noteworthy given increased notification
rates among males aged over 25 years [25]. As a result of
this audit, given the observed high prevalence of chlamy-
dia among juvenile females and the difficulties involved
in providing follow-up clinical management, juvenile
females are now offered empirical treatment for chlamy-
dia at the time of testing [26]. The higher prevalence of
gonorrhoea found among female prisoners compared
with population disease notification data is consistent
with the natural history of this infection, which tends to
be asymptomatic and persistent in females versus sympto-
matic and self-limiting in males [12,25].
The prevalences of hepatitis B and C found in this audit
were comparable with previous estimates among prison-
ers [1,3], and contrast with general population estimates
which indicate that hepatitis C is more common among
males and higher among Aboriginal people [25]. A high
prevalence of hepatitis C among adult female prisoners is
consistent with a high reported frequency of drug use
among female prisoners [27]. We also found support for
a geographical difference in the hepatitis C risk profile of
Aboriginal prisoners, where Aboriginal prisoners in
regional prisons had a significantly lower disease preva-
lence than both Aboriginal prisoners in metropolitan pris-
ons and non-Aboriginal prisoners, as has been observed
in South Australia [28].
Unfortunately RNA testing of prisoners who had hepatitis
C antibodies was not performed routinely in Western Aus-
tralia during the study period. As such, although test
results enabled appropriate counselling regarding risk
behaviours and the potential benefit of further testing or
treatment, the proportion of prisoners who had active
hepatitis C infection and would benefit from antiviral
treatment was not known. Following this audit, routine
collection of an additional blood sample for hepatitis C
RNA testing was instituted, considering the high preva-
lence of hepatitis C antibody positivity in this population,
and the benefits of antiviral treatment [29].
The HIV positivity rate found in this audit is equivalent to
that found in the 2007 National Prison Entrants Survey
[1], and considerably higher than the population-based
age-standardised notification ratio for HIV of 3.6 per
100,000 population [25]. Higher rates of HIV in prisoner
populations have been documented worldwide [5], and
the current rate of HIV among Australian prisoners is
likely to be higher than historical estimates [30].
To enable the local auditing of recent health assessment
practices in metropolitan and regional prisons, we sam-
pled recently discharged prisoners who had a relatively
short duration of imprisonment. As such the ability to
generalise our findings to the wider prisoner population
in Western Australia, and in particular to prisoners admit-
ted prior to 2006 and those with longer terms of impris-
onment, is likely to be limited. Only a small proportion of
prisoners were found to be missing an electronic record of
their initial health assessment, and exclusion of these
individuals from this audit is not likely to bias our find-
ings, as test outcomes are unlikely to be related to the
availability of a prisoner's electronic medical record.BMC Public Health 2009, 9:385 http://www.biomedcentral.com/1471-2458/9/385
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Ongoing evaluation of prisoner health programs is
needed to ensure effective policy implementation and
improved prisoner health outcomes. The adoption of
technologies such as electronic medical records [31] in
prisons would enable more comprehensive centralised
evaluation of program delivery and prisoner health out-
comes based on representative samples of the prison pop-
ulation. Evaluation methods which improve the
immediacy and completeness of feedback may also rein-
force program effectiveness by increasing the perceived
relevance and importance of program outcomes, and
enhance the potential for audit findings to improve prac-
tice. Electronic medical record systems could also facili-
tate the identification of subpopulations that require
targeted health interventions.
Conclusion
Our findings identify limitations in the documented STI
and BBV testing practices among prisoners in Western
Australia, and confirm the importance of providing com-
prehensive assessment, treatment and counselling for this
high risk population. Interventions are required to
improve the coverage of STI and BBV testing among pris-
oners on admission to prison, and ongoing program eval-
uation is essential to ensure the effective implementation
of policies designed to improve prisoner health. Deficien-
cies in prisoner health assessment practices represent
missed opportunities to improve disease control in pris-
oners and in the wider population.
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